Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 35 of 35
Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
NCT00186602
Heart Disease on the Mend
NCT00127751
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
NCT00186394
Memory and Mental Health in Aging
NCT02988908
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
NCT00238602
Genetics of Recurrent Early-Onset Depression
NCT00005914
Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
NCT00220597
The Effectiveness of Regular Exercise on Improving Sleep in Older Adults
NCT00149747
Microarray Analysis of Gene Expression in Liver Tumors
NCT00373737
Microarray Analysis of Gene Expression in Prostate Tissues
NCT00186368
Reducing Television Viewing to Prevent Childhood Obesity
NCT00185770
Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
NCT00185900
Promoting Long-term Behavior Change to Reduce CVD Risk
NCT00227006
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
NCT00186667
Obesity Prevention for Pre-Adolescents
NCT00185978
Autologous Stem Cell Rescue for Primary Amyloidosis
NCT00186407
Treatment of Schizoaffective Disorder Using Mifepristone
NCT00725270
High Dose Chemotherapy Followed By PBSC Rescue for HD
NCT00186251
Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy
NCT00003716
Low Back Pain Patient Education Evaluation
NCT00000408
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
NCT00225212
Transplantation for Patients With Chronic Lymphocytic Leukemia
NCT00186303
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
NCT00186680
Patient Education in Rheumatoid Arthritis and Osteoarthritis
NCT00000414
Toward Better Outcomes in Osteoarthritis
NCT00000425
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00002774
Molecular Analysis of Breast Cancer
NCT00569049
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
NCT00186381
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
NCT00002714
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
NCT00186238
Tap Water Versus Normal Saline for Wound Irrigation
NCT01564342
Ontogeny of Measles Immunity in Infants
NCT00240916
Group Therapy for Primary Breast Cancer
NCT00220792
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
NCT00186342
Allo BMT in Advanced Leukemia or High Grade Lymphoma
NCT00186290
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
NCT00186225
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
NCT00002715
Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)
NCT00186472
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641
Group Psychotherapy for People With HIV
NCT00186550
Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure
NCT00226850
Acupuncture and Massage for Depression During Pregnancy
NCT00186654
A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.
NCT00002111
Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?
NCT00186524
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.